Cytopathology and Histopathology

Surgical Cytopathology

Surgical Cytopathology is the most significant and time-consuming area of practice for most anatomical pathologists. Surgical Cytopathology involves the gross and microscopic examination of surgical specimens, as well as biopsies submitted by surgeons and non-surgeons such as general internists, medical subspecialists, dermatologists, and interventional radiologists. Cytology can be used to diagnose a condition and spare a patient from surgery to obtain a larger specimen.Cytopathology surgical autopsy service serves multiple important functions. In addition to routine autopsy reports, this section provides sources of material for many research activities, including retrospective studies of various diseases, case reports, comparative tissue studies and studies of various physiologic functions related to malignant disease. The service provides tissue for virologic, biochemical, molecular and electron microscopic studies.The acute ischemic stroke diagnosis and treatment market is segmented as North America, Europe, Asia-Pacific and Rest of the World (RoW). North America represented the largest regional market for acute ischemic stroke primarily due to the increase in ischemic stroke surgeries and introduction of technologically advanced medical devices and products. For instance, American Heart Association stated that, stroke is considered as the third leading cause of death in developed nations of the world such as the U.S., Canada. Moreover, it has also stated that, there are around 795,000 patient diagnosed with stroke in the U.S. every year where 85% of the total cases were identified as acute ischemic stroke. The National Institute of Health (NIH) stated that, healthcare cost for the treatment of stroke exceeds USD 73 billion in the U.S. every year. However, stringent regulatory compliance imposed by the U.S. FDA pertaining to medical device treatment utilized for human purpose (stroke) is considered as a hurdle for the growth of this market in North America. Europe accounted for the second largest share in the global acute ischemic stroke diagnosis and treatment market in 2013.